RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

JCR Pharmaceuticals Co P/S 2024

JCR Pharmaceuticals Co P/S

1.71

JCR Pharmaceuticals Co Dividend yield

3.18 %

Ticker

4552.T

ISIN

JP3701000006

WKN

889627

As of May 16, 2024, JCR Pharmaceuticals Co's P/S ratio stood at 1.71, a -65.87% change from the 5.01 P/S ratio recorded in the previous year.

The JCR Pharmaceuticals Co P/S history

JCR Pharmaceuticals Co Aktienanalyse

What does JCR Pharmaceuticals Co do?

JCR Pharmaceuticals Co. Ltd is a Japanese company founded in 1975. It is a global provider of biopharmaceutical products and services and is based in Ashiya, Japan. The company specializes in researching and developing therapies for rare genetic diseases, including the production of recombinant proteins and antibodies. It has three main business areas: biopharmaceuticals, diagnostics, and research services. JCR Pharmaceuticals works closely with universities, research institutions, and other companies to advance biotechnology research. It follows an ethical business model focused on integrity, transparency, openness, and fairness. The company has expanded into Europe and invested in a new research and development facility to enhance its presence and improve access to novel therapies for patients. Overall, JCR Pharmaceuticals has a strong position in the biotechnology and rare diseases field and has the potential to positively impact the lives of millions of people worldwide. JCR Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding JCR Pharmaceuticals Co's P/S Ratio

JCR Pharmaceuticals Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing JCR Pharmaceuticals Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating JCR Pharmaceuticals Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in JCR Pharmaceuticals Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about JCR Pharmaceuticals Co Stock

What is the price-to-earnings ratio of JCR Pharmaceuticals Co?

The price-earnings ratio of JCR Pharmaceuticals Co is currently 1.71.

How has the price-earnings ratio of JCR Pharmaceuticals Co changed compared to last year?

The price-to-earnings ratio of JCR Pharmaceuticals Co has increased by -65.87% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of JCR Pharmaceuticals Co high compared to other companies?

Yes, the price-to-earnings ratio of JCR Pharmaceuticals Co is high compared to other companies.

How does an increase in the price-earnings ratio of JCR Pharmaceuticals Co affect the company?

An increase in the price-earnings ratio of JCR Pharmaceuticals Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of JCR Pharmaceuticals Co affect the company?

A decrease in the price-earnings ratio of JCR Pharmaceuticals Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of JCR Pharmaceuticals Co?

Some factors that influence the price-earnings ratio of JCR Pharmaceuticals Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does JCR Pharmaceuticals Co pay?

Over the past 12 months, JCR Pharmaceuticals Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 3.18 %. For the coming 12 months, JCR Pharmaceuticals Co is expected to pay a dividend of 24.33 JPY.

What is the dividend yield of JCR Pharmaceuticals Co?

The current dividend yield of JCR Pharmaceuticals Co is 3.18 %.

When does JCR Pharmaceuticals Co pay dividends?

JCR Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of JCR Pharmaceuticals Co?

JCR Pharmaceuticals Co paid dividends every year for the past 24 years.

What is the dividend of JCR Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 24.33 JPY are expected. This corresponds to a dividend yield of 3.87 %.

In which sector is JCR Pharmaceuticals Co located?

JCR Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von JCR Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of JCR Pharmaceuticals Co from 6/1/2024 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did JCR Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of JCR Pharmaceuticals Co in the year 2023?

In the year 2023, JCR Pharmaceuticals Co distributed 20 JPY as dividends.

In which currency does JCR Pharmaceuticals Co pay out the dividend?

The dividends of JCR Pharmaceuticals Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von JCR Pharmaceuticals Co

Our stock analysis for JCR Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JCR Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.